Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties

Acta Pharmaceutica

Volumn 59, Issue 2, 2009, Pages 223-233

  Husain, Asif ^a   Ajmal, Mohammed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

1,3,4 oxadiazoles; Analgesic activity; Anti in flammatory; Antibacterial activity; Aroylpropionic acid

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; 2 [3 (4 BROMOPHENYL) PROPAN 3 ONE] 5 (4 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2 [3 (4 BROMOPHENYL)PROPAN 3 ONE] 5 (3,4 DIMETHOXY PHENYL) 1,3,4 OXADIAZOLE; 2 [3 (4 BROMOPHENYL)PROPAN 3 ONE] 5 (4 CHLOROPHENYL) 1,3,4 OXADIAZOLE; 2 [3 (4 BROMOPHENYL)PROPAN 3 ONE] 5 (4 FLUOROPHENYL) 1,3,4 OXADIAZOLE; 2 [3 (4 BROMOPHENYL)PROPAN 3 ONE] 5 (PHENYL) 1,3,4 OXADIAZOLE DERIVATIVE; 3 (4 BROMOBENZOYL)PROPIONIC ACID; ARYL ACID ETHYL ESTER DERIVATIVE; ARYL ACID HYDRAZIDE; ESTER DERIVATIVE; HYDRAZIDE DERIVATIVE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IRRADIATION; MALE; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 67651180633     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0011-1     Document Type: Article

References (17)

1. F. A. Omar, N. M. Mahfouz and M. A. Rahman, Design, synthesis and anti-inflammatory activity of some 1,3,4-oxadiazole derivatives, Eur. J. Med. Chem. 31 (1996) 819-825; DOI: 10.1016/0223--5234(96)83976-6.
2. B. Narayana, K. K. Vijayaraj, B. V. Ashlatha and N. S. Kumari, Synthesis of some new 2-(6-me-thoxy-2-naphthyl)-5-aryl-1,3,4-oxadiazoles as possible non-steroidal anti-inflammatory and analgesic agents, Arch. Pharm. (Weinheim) 338 (2005) 373-377; DOI: 10.1002/ardp.200400964.
3. M. Amir and S. Kumar, Synthesis and evaluation of anti-inflammatory analgesic and lipid peroxidation properties of ibuprofen derivatives, Acta Pharm. 57 (2007) 31-45; DOI: 10.2478/v10007--007-0003-y
4. S. L. Gaonkar, K. M. Rai and B. Prabhuswamy, Synthesis and antimicrobial studies of a new series of 2-{4-[2-(5-ethylpyridin-2-yl)ethoxy] phenyl}-5-substituted-1,3,4-oxadiazoles, Eur. J. Med. Chem. 41 (2006) 841-846; DOI: 10.1002/chin.200651110.
5. M. A. Ali and M. S. Yar, Oxadiazole Mannich bases: Synthesis and antimycobacterial activity, Bioorg. Med. Chem. Lett. 17 (2007) 3314-3316; DOI: 10.1016/j.bmcl.2007.04.004.
6. A. Zarghi, S. A. Tabatabai, M. Faizi, A. Ahadian, P. Navabi, V. Zanganeh and A. Shafiee, Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazole, Bioorg. Med. Chem. Lett. 15 (2005) 1863-1865; DOI: 10.1016/j.bmcl.2005.02.014.
7. T. M. Tan, Y. Chen, K. H. Kong, J. Bai, Y Li, S. G. Lim, T. H. Ang and Y Lam, Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5- substituted-sulfanyl-(1,3,4)-oxadiazoles as potential anti-hepatitis B virus agents, Antiviral Res. 71 (2006) 7-14; DOI: 10.1016/j.antiviral. 2006. 02.007.
8. F. L. Lanza, A guideline for the treatment and prevention of NSAID-induced ulcers, Am. J. Gastroenterol. 93 (1998) 2037-2046; DOI: 10.1016/S0002-9270(98)00469-9.
9. F. Buttgereit, G Burmester and L. S. Simon, Gastrointestestinal toxic side effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2- specific inhibitors, Am. J. Med. 110 (2001) 135-195; DOI: 10.10116/S0002-9343(00)00728-2.
10. K. A. Metwally, S. H. Yaseen, E. M. Lashine, H. M. El-Fayomi and M. E. El-Sadek, Non-carbo-xylic analogues of aroylpropionic acids: Synthesis, anti-inflammatory activity and ulcerogenic potential, Eur. J. Med. Chem. 42 (2007) 152-160.
11. V. Cioli, S. Putzolu, V. Rossi, P. S. Barcellona and C. Corradino, The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats, Toxicol. Appl. Pharmacol. 50 (1979) 283-289; DOI: 10.1016/0041-008X(79)90153-4.
12. A. Husain, M. S. Y. Khan, S. M. Hasan and M. M. Alam, 2-Arylidene-4-(4-phenoxy-phenyl)but--3-en-4-olides: Synthesis, reactions and biological activity, Eur. J. Med. Chem. 40 (2005) 1394-1404; DOI: 10.1002/chin.200617109.
13. M. S. Y. Khan and A. Husain, Syntheses and reactions of some new 2-arylidene-4-(biphenyl-4--yl)but-3-en-4-olides with a study of their biological activity, Pharmazie 57 (2002) 448-452.
14. N. Siddiqui, M. S. Alam and W. Ahsan, Synthesis, anticonvulsant and toxicity evaluation of 2-(1H--indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocy-clic derivatives, Acta Pharm. 58 (2008) 445-454; DOI: 10.2478/v10007-008-0025-0.
15. C. A. Winter, E. A. Risley and G. W. Nuss, Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. 111 (1962) 544-547.
16. H. O. Collier, L. C. Dinneen, C. A. Johnson and C. Schneider, The abdominal constriction response and its suppression by analgesic drugs in the mouse, Br. J. Pharmacol. 32 (1968) 295-310.
17. R. Cruickshank, J. P. Dugid, D. P. Marmion and R. H. A. Swain, Medical Microbiology, Vol. 2, Churchill, London 1975.